Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Dec 7;11(45):7169-73.
doi: 10.3748/wjg.v11.i45.7169.

Bone disorders in experimentally induced liver disease in growing rats

Affiliations

Bone disorders in experimentally induced liver disease in growing rats

Viktória Ferencz et al. World J Gastroenterol. .

Abstract

Aim: To investigate the change of bone parameters in a new model of experimentally induced liver cirrhosis and hepatocellular carcinoma (HCC) in growing rats.

Methods: Fischer-344 rats (n = 55) were used. Carbon tetrachloride (CCl(4)), phenobarbital (PB), and a single diethylnitrosamine (DEN) injection were used. Animals were killed at wk 8 and 16. Bone mineral content, femoral length, cortical index (quotient of cortical thickness and whole diameter) and ultimate bending load (F(max)) of the femora were determined. The results in animals treated with DEN+PB+CCl(4) (DPC, n = 21) were compared to those in untreated animals (UNT, n = 14) and in control group treated only with DEN+PB (DP, n = 20).

Results: Fatty liver and cirrhosis developed in each DPC-treated rat at wk 8 and HCC was presented at wk 16. No skeletal changes were found in this group at wk 8, but each parameter was lower (P<0.05 for each) at wk 16 in comparison to the control group. Neither fatty liver nor cirrhosis was observed in DP-treated animals at any time point. Femoral length and F(max) values were higher (P<0.05 for both) in DP-treated animals at wk 8 compared to the UNT controls. However, no difference was found at wk 16.

Conclusion: Experimental liver cirrhosis and HCC are accompanied with inhibited skeletal growth, reduced bone mass, and decreased mechanical resistance in growing rats. Our results are in concordance with the data of other studies using different animal models. A novel finding is the transiently accelerated skeletal growth and bone strength after a 8-wk long phenobarbital treatment following diethylnitrosamine injection.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean±SD of femur length (A), cortical index of femoral midshaft (B), BMC of femur in mid-point of medial diaphysis (C), and ultimate bending load of femoral midshaft (D) in UNT, DP-treated control and DPC-treated rats at wk 8 and 16. A: 1P = 0.020, 2P = 0.002 vs DPC-16, 3P = 0.001 vs UNT-8, bP<0.001 vs UNT-8, dP<0.001 vs DP-8, fP<0.001 vs DPC-8; B: 4P = 0.018 vs UNT-8,5P = 0.013 vs DP-8, 6P = 0.004 vs DPC-16; C:7P = 0.001 vs DPC-16, 8P = 0.002 vs UNT-8, 9P = 0.016 vs DPC-16, 10P = 0.003 vs DP-8; D: hP<0.001 vs DPC-16, jP<0.001 vs UNT-8, lP<0.001 vs DPC-16, nP<0.001 vs UNT-8.

Similar articles

Cited by

References

    1. Diamond T, Stiel D, Lunzer M, Wilkinson M, Roche J, Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut. 1990;31:82–87. - PMC - PubMed
    1. Heathcote J. Osteoporosis in chronic liver disease. Curr Gastroenterol Rep. 1999;1:455–458. - PubMed
    1. McCaughan GW, Feller RB. Osteoporosis in chronic liver disease: pathogenesis, risk factors, and management. Dig Dis. 1994;12:223–231. - PubMed
    1. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodes J, Munoz-Gomez J. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int. 1997;60:148–154. - PubMed
    1. Corazza GR, Trevisani F, Di Stefano M, De Notariis S, Veneto G, Cecchetti L, Minguzzi L, Gasbarrini G, Bernardi M. Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis. Dig Dis Sci. 2000;45:1392–1399. - PubMed

Publication types